← Browse by Condition
Medical Condition
malignant melanoma
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1
NCT06985056
Recruiting
Reducing Symptom Burden Through Physical Exercise in Melanoma Patients
Enrollment
104 pts
Location
Germany
Sponsor
Universität Duisburg-Essen
NCT04282044 Phase 1
Recruiting
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Enrollment
60 pts
Location
United States
Sponsor
BioEclipse Therapeutics
NCT02828202
Recruiting
Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
Enrollment
6,000 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT05130255 Phase 1
Recruiting
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
Enrollment
60 pts
Location
United States
Sponsor
Y-mAbs Therapeutics